The U.S. Food and Drug Administration has approved the FluMist Quadrivalent, the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains.
Read the full report in Becker’s Hospital Review on FluMist Quadrivalent.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.